Roche faces high fines for excessive pricing
Shutterstock/diy13
The Competition Commission of South Africa has asked the country’s specialist tribunal to fine Roche and two of its subsidiaries for excessively pricing a life-saving breast cancer treatment drug for nearly a decade.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now